3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Pancreatic Neoplasms
18
Breast Neoplasms
10
Carcinoma, Non-Small-Cell Lung
6
Triple Negative Breast Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Neoplasm Metastasis
4
Stomach Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Pancreatic Adenocarcinoma
2
Lung Neoplasms
2
Inflammatory Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Solid Cancer
1
Sarcoma
1
Oropharyngeal Neoplasms
1
Non-Small Cell Lung Cancer Metastatic
1
Non Small Cell Lung Cancer NSCLC
1
Neoplasms
1
Mouth Neoplasms
1
Lymphoma, Non-Hodgkin
1
Locally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy
1
Lip Neoplasms
1
Leukemia-Lymphoma, Adult T-Cell
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Invasive Breast Cancer
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Interventions
Temozolomide
8
sargramostim
2
pembrolizumab
2
Radiotherapy
2
Radiation
2
veliparib
1
selinexor
1
montanide ISA 51
1
lonafarnib
1
Vorinostat
1
Sucrose
1
Sonication
1
Sodium Chloride
1
Serotonin Antagonists
1
Salts
1
Photons
1
Perfusion Magnetic Resonance Imaging
1
Olanzapine
1
Mycophenolic Acid
1
Magnetic Resonance Spectroscopy
1
Loperamide
1
Lomustine
1
Irinotecan
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Drug Therapy
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
Carboplatin
1
CLR1404
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Gliosarcoma
×
Albumin-Bound Paclitaxel
×
Clear all
NCT04528680
2026-04-13
SC9/ABX
Northwestern University
Phase 1/2
Active not recruiting
57 enrolled